<i>In Silico</i> Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes

<table>Disorder disposition of AMPK-modeled structure. Main residues (Val18 to ASP151) are in the nondisordered region (below the red line).</table>

Evidence-Based Complementary and Alternative Medicine

fig6

Figure 6

Figure 6: <i>In Silico</i> Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes 

Figure 6 | In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes 